Showing results (61-70 of 327) with videos related to
Sort By:
Pageof 33
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1993
Rates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bileM J Seaton, G A Kyerematen, E S VesellThe Journal of Clinical Investigation|May 1, 1985
Polymorphism of theophylline metabolism in manC A Miller, L B Slusher, E S VesellCancer Research|December 1, 1976
Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytesS A Atlas, E S Vesell, D W NebertClinical Pharmacology and Therapeutics|December 1, 1978
Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect themG E Poley, C A Shively, E S VesellClinical Pharmacology and Therapeutics|August 1, 1993
Reproducibility of antipyrine half-lives in elderly subjectsE S Vesell, T M DeAngelo, I R KatzPharmacology|January 1, 1983
Influence of different forms of tobacco intake on nicotine elimination in manG A Kyerematen, B H Dvorchik, E S VesellClinical Pharmacology and Therapeutics|March 1, 1978
Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthinesD D Drouillard, E S Vesell, B H DvorchikProceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twinsM B Penno, B H Dvorchik, E S VesellPharmacology|March 1, 1996
Studies on pyrazinoylguanidine. 2. Comparative drug and dose effects on glucose and lipid metabolism in streptozotocin-induced diabetic ratsY I A-Rahim, K H Beyer, E S VesellPharmacology|March 1, 1996
Studies on pyrazinoylguanidine. 1. Characterization of metabolic effects in diabetic ratsY I A-Rahim, K H Beyer, E S VesellPageof 33